Performance of a quantitative human immunodeficiency virus type 1 p24 antigen assay on various HIV-1 subtypes for the follow-up of human immunodeficiency type 1 seropositive individuals

被引:27
|
作者
Ribas, SG
Ondoa, P
Schüpbach, J
van der Groen, G
Fransen, K
机构
[1] Inst Trop Med, B-2000 Antwerp, Belgium
[2] Univ Zurich, Swiss Natl Ctr Retroviruses, Zurich, Switzerland
关键词
HIV-1; RNA; viral load; heat-denatured p24 antigen; HIV subtypes;
D O I
10.1016/S0166-0934(03)00219-2
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The heat-denatured signal-amplified p24 antigen assay is a low-cost test allowing the determination of plasma levels of HIV-1 p24 antigen in infected patients. This assay may be appropriate for monitoring disease progression in HIV seropositive patients in developing countries. Only a few data on the clinical validation of the test are available for HIV-1 non-subtypes B viruses that represent the vast majority of virus circulating in Africa. The present study was undertaken to evaluate and compare the performance of a heat-denatured signal-amplified p24 assay for the determination of p24 viral load in the plasma of individuals infected with different subtypes of HIV-1 and using the RT-PCR-based RNA viral load test as the gold standard. A total of 120 plasma samples from individuals infected with HIV-1 strains belonging to group M (subtypes A --> H) and group O, as well as recombinant strains, were tested in parallel with the heat-denatured signal-amplified p24 assay and the RNA viral load. Plasma p24 levels appeared to be correlated significantly with the plasma RNA viral loads (R = 0.751, P < 0.0001). The heat-denatured p24 antigen assay was capable of measuring the plasma level of p24 derived from all the HIV-1 subtypes and recombinants selected for this study, in contrast to the RNA viral load test which lacked sensitivity towards HIV-1 group O. The heat-denatured signal-amplified p24 assay is a reliable, sensitive and a more affordable tool that can be used for the follow-up of patients infected with B and non-B subtypes as well as recombinant forms of HIV-1 in developing countries. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:29 / 34
页数:6
相关论文
共 50 条
  • [21] Nanoparticle-based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen
    Tang, Shixing
    Zhao, Jiangqin
    Storhoff, James J.
    Norris, Philip J.
    Little, Richard F.
    Yarchoan, Robert
    Stramer, Susan L.
    Patno, Tim
    Domanus, Marc
    Dhar, Arindam
    Mirkin, Chad A.
    Hewlett, Indira K.
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (02) : 231 - 237
  • [22] Production of human immunodeficiency virus type 1 (HIV-1) pseudoviruses using linear HIV-1 envelope expression cassettes
    Beels, Dominique
    Heyndrick, Leo
    Vereecken, Katleen
    Vermoesen, Tine
    Michiels, Lieve
    Vanham, Guido
    Kestens, Luc
    JOURNAL OF VIROLOGICAL METHODS, 2008, 147 (01) : 99 - 107
  • [23] Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
    Nukuna A.
    Gendelman H.E.
    Limoges J.
    Rasmussen J.
    Poluektova L.
    Ghorpade A.
    Persidsky Y.
    Journal of NeuroVirology, 2004, 10 (Suppl 1) : 82 - 90
  • [24] Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis
    Nukuna, A
    Gendelman, HE
    Limoges, J
    Rasmussen, J
    Poluektova, L
    Ghorpade, A
    Persidsky, Y
    JOURNAL OF NEUROVIROLOGY, 2004, 10 : 82 - 90
  • [25] Assembling the human immunodeficiency virus type 1
    Cimarelli, A
    Darlix, JL
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2002, 59 (07) : 1166 - 1184
  • [26] Lack of predictive value for progression of dissociated circulating p24 antigen in human immunodeficiency virus type 1-infected black patients
    Prazuck, T
    Troisvallets, D
    Vallantin, X
    Patey, O
    Matta, M
    Fisch, A
    Lesguiller, C
    Mohamed, AS
    Thomas, M
    Lafaix, C
    Belec, L
    JOURNAL OF MEDICAL VIROLOGY, 1996, 50 (02) : 181 - 187
  • [27] Nucleolin and the packaging signal, ψ, promote the budding of human immunodeficiency virus type-1 (HIV-1)
    Ueno, T
    Tokunaga, K
    Sawa, H
    Maeda, M
    Chiba, J
    Kojima, A
    Hasegawa, H
    Shoya, Y
    Sata, T
    Kurata, T
    Takahashi, H
    MICROBIOLOGY AND IMMUNOLOGY, 2004, 48 (02) : 111 - 118
  • [28] Neuropsychological examination of cognitive impairment in human immunodeficiency virus type-1 (HIV-1) infection
    Clemente-Millana, L
    Portellano, JA
    REVISTA DE NEUROLOGIA, 2000, 31 (12) : 1192 - 1201
  • [29] DETECTION OF HIV-1 RNA AND P24 ANTIGEN IN HIV-1-INFECTED HUMAN LIVER
    HOUSSET, C
    LAMAS, E
    BRECHOT, C
    RESEARCH IN VIROLOGY, 1990, 141 (02): : 153 - &
  • [30] HIV-1 p24 vaccine protects cats against feline immunodeficiency virus infection
    Coleman, JK
    Pu, RY
    Martin, M
    Sato, E
    Yamamoto, JK
    AIDS, 2005, 19 (14) : 1457 - 1466